Catabasis Pharmaceuticals, Inc. logo
Catabasis Pharmaceuticals, Inc. CATB
$ 8.54 -6.97%

Catabasis Pharmaceuticals, Inc. Financial Statements 2011-2024 | CATB

Annual Financial Statements Catabasis Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

80.6 M 61.9 M 31.1 M 32.1 M 63.8 M 53.2 M - - - -

Shares

19.4 M 11.2 M 5.05 M 2.17 M 1.62 M 804 K - - - -

Net Income

-37.3 M -26.3 M -25.9 M -27.4 M -36.1 M -32.6 M -21.9 M -18.1 M - -

Revenue

- - - 500 K - - - - - -

EBITDA

-37.4 M -27.1 M -26.3 M -26.8 M -35.2 M -31.5 M -21.4 M -17.8 M - -

Operating Expenses

37.4 M 27.1 M 26.4 M 27.6 M 35.6 M 31.7 M - - - -

General and Administrative Expenses

11.8 M 8.77 M 9.33 M 8.91 M 10.1 M 8.63 M 6 M 4.12 M - -

All numbers in USD currency